Terns Pharmaceuticals
TERN
TERN
126 hedge funds and large institutions have $447M invested in Terns Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 45 increasing their positions, 24 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
13% more funds holding
Funds holding: 112 → 126 (+14)
8% more capital invested
Capital invested by funds: $415M → $447M (+$31.8M)
3.58% more ownership
Funds ownership: 97.82% → 101.4% (+3.6%)
Holders
126
Holding in Top 10
3
Calls
$3.72M
Puts
$809K
Top Buyers
| 1 | +$33.7M | |
| 2 | +$7.3M | |
| 3 | +$6.51M | |
| 4 |
BlackRock
New York
|
+$5.48M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$5.07M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$13.1M | |
| 3 | -$10.3M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
-$8.95M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$8.79M |